Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pujan N. Pandya, Sivakumar Prasanth Kumar, Kinjal Bhadresha, Chirag N. Patel, Saumya K. Patel, Rakesh M. Rawal & Archana U. Mankad. (2020) Identification of promising compounds from curry tree with cyclooxygenase inhibitory potential using a combination of machine learning, molecular docking, dynamics simulations and binding free energy calculations. Molecular Simulation 46:11, pages 812-822.
Read now
Read now
Axel H Schönthal, Thomas C Chen, Florence M Hofman, Stan G Louie & Nicos A Petasis. (2008) Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs. Expert Opinion on Investigational Drugs 17:2, pages 197-208.
Read now
Read now
. (2004) Carbonic anhydrase/COX-2 inhibitors in the treatment of various diseases. Expert Opinion on Therapeutic Patents 14:12, pages 1803-1806.
Read now
Read now
Articles from other publishers (28)
Víctor M. Villaseñor, Jhony Navat Enriquez-Vara, Judith E. Urías-Silva, Eugenia del Carmen Lugo-Cervantes, Diego A. Luna-Vital & Luis Mojica. (2022) Mexican grasshopper (Sphenarium purpurascens) as source of high protein flour: Techno-functional characterization, and in silico and in vitro biological potential. Food Research International 162, pages 112048.
Crossref
Crossref
Mehlika D. Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, İpek Ertorun, Özkan Alataş & Ahmet Özdemir. (2022) A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition. Archiv der Pharmazie 355:9, pages 2200136.
Crossref
Crossref
V.M. Berlin Grace, D. David Wilson, R. Anushya & Siddikuzzaman. (2021) Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA). Life Sciences 285, pages 119967.
Crossref
Crossref
Monika Berbecka, Alicja Forma, Jacek Baj, Marzena Furtak-Niczyporuk, Ryszard Maciejewski & Robert Sitarz. (2021) A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. Journal of Clinical Medicine 10:19, pages 4443.
Crossref
Crossref
Ka Woong Wong & Siau Hui Mah. 2021. Bioactive Natural Products. Bioactive Natural Products
393
433
.
Benjamin L. Woolbright, Carol C. Pilbeam & John A. TaylorIIIIII. (2020) Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials. Prostaglandins & Other Lipid Mediators 148, pages 106409.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerShuh Narumiya, Takehiko Yokomizo & Junken Aoki. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
651
694
.
B. Ahmetaj-Shala, A. Tesfai, C. Constantinou, R. Leszczynski, M.V. Chan, H. Gashaw, G. Galaris, S. Mazi, T.D. Warner, N.S. Kirkby & J.A. Mitchell. (2017) Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killing. Biochemical and Biophysical Research Communications 484:4, pages 762-766.
Crossref
Crossref
Philipp Krapf, Raphael Richarz, Elizaveta A. Urusova, Bernd Neumaier & Boris D. Zlatopolskiy. (2015)
Seyferth–Gilbert Homologation as a Route to
18
F‐Labeled Building Blocks: Preparation of Radiofluorinated Phenylacetylenes and Their Application in PET Chemistry
. European Journal of Organic Chemistry 2016:3, pages 430-433.
Crossref
Crossref
Hai-Kang Hua, Cheng Jin, Li-Jia Yang, Shi-Qin Tao & Xiao-Hong Zhu. (2015) Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance. Cell Biochemistry and Biophysics 72:2, pages 475-480.
Crossref
Crossref
Claudio Tabolacci, Alessandro Lentini, Bruno Provenzano, Angelo Gismondi, Stefania Rossi & Simone Beninati. (2010) Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells. Melanoma Research 20:4, pages 273-279.
Crossref
Crossref
C. Chargari, E. Deutsch, C. Le P?choux & N. Magn?. (2009) ?tat des lieux des associations chimioradioth?rapeutiques et place potentielle des th?rapies cibl?es dans les cancers bronchiques non ? petites cellules. Cancer/Radioth?rapie 13:2, pages 114-122.
Crossref
Crossref
Carol A. Rouzer & Lawrence J. Marnett. (2009) Cyclooxygenases: structural and functional insights. Journal of Lipid Research 50, pages S29-S34.
Crossref
Crossref
Deepika Dhawan, Antonella Borgatti Jeffreys, Rong Zheng, Jane C. Stewart & Deborah W. Knapp. (2008) Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Molecular Cancer Therapeutics 7:4, pages 897-904.
Crossref
Crossref
Dana Yona & Nadir Arber. (2006) Coxibs and Cancer Prevention. Journal of Cardiovascular Pharmacology 47:Supplement 1, pages S76-S81.
Crossref
Crossref
Axel H. Schönthal. (2006) Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy. Neurosurgical Focus 20:4, pages E21.
Crossref
Crossref
J.O. Moody, V.A. Robert, J.D. Connolly & P.J. Houghton. (2006) Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). Journal of Ethnopharmacology 104:1-2, pages 87-91.
Crossref
Crossref
Moammir H. Aziz, Deric L. Wheeler, Bhushan Bhamb & Ajit K. Verma. (2006) Protein Kinase C δ Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation–Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2. Cancer Research 66:2, pages 713-722.
Crossref
Crossref
Vattoly J. Majo, Jaya Prabhakaran, Norman R. Simpson, Ronald L. Van Heertum, J. John Mann & J.S. Dileep Kumar. (2005) A general method for the synthesis of aryl [11C]methylsulfones: Potential PET probes for imaging cyclooxygenase-2 expression. Bioorganic & Medicinal Chemistry Letters 15:19, pages 4268-4271.
Crossref
Crossref
D J A de Groot, T Timmer, D C J Spierings, T K P Le, S de Jong & E G E de Vries. (2005) Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells. British Journal of Cancer 92:8, pages 1459-1466.
Crossref
Crossref
J. W. Pollard. (2005) Review of: Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation. Breast Cancer Online 8:2.
Crossref
Crossref
Guido Eibl, Yasunori Takata, Laszlo G. Boros, Joey Liu, Yuji Okada, Howard A. Reber & Oscar J. Hines. (2005) Growth Stimulation of COX-2–Negative Pancreatic Cancer by a Selective COX-2 Inhibitor. Cancer Research 65:3, pages 982-990.
Crossref
Crossref
Christian Kamp Nielsen, Joan I.A. Campbell, John F. Öhd, Matthias Mörgelin, Kristian Riesbeck, Göran Landberg & Anita Sjölander. (2005) A Novel Localization of the G-Protein-Coupled CysLT1 Receptor in the Nucleus of Colorectal Adenocarcinoma Cells. Cancer Research 65:3, pages 732-742.
Crossref
Crossref
Guido Eibl, Howard A. Reber, Oscar J. Hines & Vay L. W. Go. (2004) COX and PPAR. Pancreas 29:4, pages 247-253.
Crossref
Crossref
Hassan Fahmi. (2004) mPGES-1 as a novel target for arthritis. Current Opinion in Rheumatology 16:5, pages 623-627.
Crossref
Crossref
Ignacio I. Wistuba & Adi F. Gazdar. (2004) Gallbladder cancer: lessons from a rare tumour. Nature Reviews Cancer 4:9, pages 695-706.
Crossref
Crossref
Saranette Cheng, Hassan Afif, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Xinfang Li, Katherine Farrajota, Martin Lavigne & Hassan Fahmi. (2004) Activation of Peroxisome Proliferator-activated Receptor γ Inhibits Interleukin-1β-induced Membrane-associated Prostaglandin E2 Synthase-1 Expression in Human Synovial Fibroblasts by Interfering with Egr-1. Journal of Biological Chemistry 279:21, pages 22057-22065.
Crossref
Crossref
Gary B. Gordon, Gary J. Kelloff & Caroline C. C. Sigman. 2004. Cancer Chemoprevention. Cancer Chemoprevention
87
105
.